Skip to main content
Clinical Trials/TCTR20230314001
TCTR20230314001
Completed
Phase 1

Outcomes of care for patients with residual symptoms of COVID-19 infection with lifestyle medicine and integrative medicine

Chao Phya Abhaibhubejhr hospital foundation0 sites20 target enrollmentMarch 14, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Post COVID-19 syndrome
Sponsor
Chao Phya Abhaibhubejhr hospital foundation
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 14, 2023
End Date
March 13, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • aged 20\-60 years old
  • The patients had main symptoms of fatigue and/or difficulty breathing after recovering from COVID\-19 with mMRC (Modified Medical Research Council) Dyspnea Scale more than 2\.

Exclusion Criteria

  • History of pulmonary embolism
  • History of severe respiratory disease
  • History of heart disease
  • Abnormal of liver and renal functions.

Outcomes

Primary Outcomes

Not specified

Similar Trials